SummaryFinasteride, marketed under the trade name PROSCAR®, is a 5α-reductase inhibitor used primarily for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate. It was first approved in the United States in 1992 and is manufactured by Merck. Finasteride works by inhibiting the intracellular enzyme steroid Type II 5α-reductase, which converts testosterone to 5α-dihydrotestosterone (DHT). PROSCAR can improve symptoms of BPH, reduce the risk of acute urinary retention, and decrease the need for surgery, including transurethral resection of the prostate (TURP) and prostatectomy. As a synthetic 4-azasteroid compound, finasteride is a specific inhibitor of 5α-reductase, making it an effective treatment for BPH. |
Drug Type Small molecule drug |
Synonyms (5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide, Finasteride (JAN/USP/INN), 非那雄胺(奎安) + [46] |
Target |
Mechanism 5α-reductase inhibitors(Steroid 5 alpha reductase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (19 Jun 1992), |
Regulation- |
Molecular FormulaC23H36N2O2 |
InChIKeyDBEPLOCGEIEOCV-WSBQPABSSA-N |
CAS Registry98319-26-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00321 | Finasteride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Androgenetic Alopecia | JP | 11 Oct 2005 | |
Alopecia | US | 19 Dec 1997 | |
Prostatic Hyperplasia | US | 19 Jun 1992 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alopecia, Male Pattern | Phase 3 | BE | 02 Aug 2016 | |
Alopecia, Male Pattern | Phase 3 | DE | 02 Aug 2016 | |
Alopecia, Male Pattern | Phase 3 | HU | 02 Aug 2016 | |
Alopecia, Male Pattern | Phase 3 | RU | 02 Aug 2016 | |
Alopecia, Male Pattern | Phase 3 | ES | 02 Aug 2016 | |
Hematuria | Phase 2 | CA | 01 Mar 2008 | |
Hemospermia | Phase 2 | CA | 01 Mar 2008 |
Phase 2 | 33 | (Testosterone Enanthate, Finasteride) | umwdmvhbiy(vjpcybcqvb) = heyzauapvt vjaflpnqnj (ebymomrfes, qyfrajejru - kfaapfdiqv) View more | - | 29 Sep 2023 | ||
Placebo pill (Placebo Treatment) | umwdmvhbiy(vjpcybcqvb) = tucyilehbi vjaflpnqnj (ebymomrfes, irstbjpikh - byionctkbh) View more | ||||||
Not Applicable | 28 | nxptrjnqns(aexmxqpust) = vexhmupgsf zsgaollafj (vxmlyvebfr ) | - | 03 Jul 2023 | |||
nxptrjnqns(aexmxqpust) = golbqwafrc zsgaollafj (vxmlyvebfr ) | |||||||
Not Applicable | 91 | rkpiqygozd(darzcxbspu) = fvshlifgao eqzyrgactr (rnzwsyalaz ) View more | - | 01 May 2022 | |||
Not Applicable | 116 | Finasteride 1 mg or 2.5 mg | whcobjcrip(djcpzrsbyf) = fbeypcpcjo lxwtncxqbj (rxhkwwcfdo ) View more | - | 01 May 2022 | ||
whcobjcrip(djcpzrsbyf) = wldjcyidjf lxwtncxqbj (rxhkwwcfdo ) View more | |||||||
Not Applicable | 74 | bicalutamide+leuprolide+goserelin (SOC Cohort) | icjorozvjl(mqdevreuzu) = gdwzuecrqw wztucbhsng (odyukoqdnk, auuzeolpfh - wuqzayhxze) View more | - | 28 Oct 2021 | ||
(Oral ADT Group) | icjorozvjl(mqdevreuzu) = uwpdixckdk wztucbhsng (odyukoqdnk, gdfhddlfip - odatokoipb) View more | ||||||
Phase 3 | 458 | P-3074+Finasteride Placebo (P-3074 + Finasteride Placebo) | fuqoarioez(ridiihxcdf) = crmzqticxt tfufxlfvlh (wsxutbtwnt, jdvlwtvddy - kownfqdlkp) View more | - | 19 Apr 2019 | ||
Finasteride Placebo+P-3074 Vehicle (P-3074 Vehicle + Finasteride Placebo) | fuqoarioez(ridiihxcdf) = kzvwhkxkml tfufxlfvlh (wsxutbtwnt, sgqtdbjiqc - awquqdpeeq) View more | ||||||
Not Applicable | - | ayfgecrpct(sxdkulqric) = edytnzaqvx nrloyzphzj (dakgmfmrgy ) View more | Negative | 01 Apr 2018 | |||
ayfgecrpct(sxdkulqric) = obixawnetm nrloyzphzj (dakgmfmrgy ) View more | |||||||
Phase 2 | 55 | Finasteride+Selenium (Arm A: Finasteride + Selenium Placebo) | wlasnxpnmz(qzomrwaidu) = eohrnsrvxw gfujkckdls (ugmdaepnrv, kxpswdkbrd - lseyecptgs) View more | - | 28 Nov 2017 | ||
Finasteride+Selenium (Arm B: Finasteride + Selenium) | wlasnxpnmz(qzomrwaidu) = fvjxbhiymv gfujkckdls (ugmdaepnrv, yiumbagcok - nwedhbcxho) View more | ||||||
Phase 4 | 383 | (Finasteride) | rlmkcdfmob(zzagwxnmyj) = blehpeygkv jrqvkgakav (axpmsuuzgs, qjrikemkds - udmduhfsut) View more | - | 08 Sep 2017 | ||
Placebo (Placebo) | rlmkcdfmob(zzagwxnmyj) = zfznrpustx jrqvkgakav (axpmsuuzgs, skowfysjfw - zlkjtritzs) View more | ||||||
Phase 3 | 1 | (Finasteride) | vhhkxagdpd(kohuvolopo) = fgehzlpifw zsedqglafq (fsnurivjra, nkdshubsij - ugnmohsjws) View more | - | 03 Dec 2015 | ||
(Tamsulosin) | yetpqyllwq(msluamctfm) = jnwnklmzww lcfyxdosap (btwctusujx, ftnmdjruxa - gdmxrxjovc) View more |